Xyonhealth

Xyonhealth operates a direct-to-consumer telemedicine platform focused on prescription hair-loss and skin therapies for men and women. The assortment centers on compounded oral and topical finasteride, minoxidil blends, and adjunct scalp care topicals, all priced at a premium tier—typically USD $70–$110 per 30-day supply. Sales are online-only through xyonhealth.com; patients complete a virtual consult and, if approved, receive medication shipped from partner pharmacies. The brand differentiates by pairing Canadian-licensed physicians with its own proprietary “SiloxysSystem” topical gel vehicle that is engineered to localize finasteride delivery and reduce systemic exposure. All formulations are customized to dosage and vehicle preference, and ongoing progress monitoring is bundled into the subscription. This precision, pharma-grade positioning has made its compounded finasteride gel the flagship offer cited in medical hair-restoration forums. Core buyers are 25-45-year-old North American professionals who want prescription-strength regrowth therapy without clinic visits or systemic side-effects; sustainability and transparent ingredient sourcing are secondary values. Customers tend to research extensively, favor science-backed claims, and are comfortable paying extra for personalized medical oversight. Xyonhealth competes against generic pill distributors, big-pharma topicals, and other tele-dermatology startups. It separates itself by emphasizing physician-guided customization, a proprietary low-systemic drug-delivery technology, and a tightly curated portfolio devoted solely to hair and scalp—positioning the brand as a premium, medically precise alternative to one-size-fits-all OTC and commodity Rx options.